- Display 15 Products per page
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in ‘Theranostics’ and Personalized Medicine)
Published: June 1, 2008 | Price: $2,995.00 – $5,990.00
This Kalorama Information report, Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine) is truly a real-world guide to the potential market for companion diagnostics. Essentially the co-development of testing products to enhance the value and efficacy of a therapeutic, companion diagnostics is widely seen as an important growth strategy in both the diagnostic and pharmaceutical industries. It is envisioned as a pathway to personalized medicine, where the right therapeutic is...
The Market for Inherited Disease Molecular Diagnostic Testing
Published: October 13, 2017 | Price: $2,000.00 – $4,000.00
The Market for Inherited Disease Molecular Diagnostic Testing The detection of single nucleotide polymorphisms (SNPs) or gene variants from tissue, blood, urine and saliva samples can be used to diagnose inherited diseases and genetic disorders as well as determine the risk of disease manifestation or progression. Point mutations in genomic DNA occur when a single nucleotide (A,T,C, or G) sequence is altered. Many SNPs have no effect on cell function, but scientists believe others could predispose people to disease or...
The Global Market for Medical Devices, 4th Edition
Published: May 1, 2013 | Price: $750.00 – $1,995.00
The Global Market for Medical Devices, 4th. Edition- Medical device makers faced challenging year in 2012. New taxes in the United States, financial tightening and regulatory threats in Europe. They consolidated, launched new devices and invested in R&D in response. In this report, The Global Market for Medical Devices, 4th. Edition, Kalorama Information analyzes the current device market in the United States, Europe, Asia and globally, profiles the key players and discusses trends important for market watchers to know. The...
Diabetes in Germany: The Markets for Monitoring, Insulin, Oral Hypoglycemics, and Drugs to Treat Complications
Published: April 1, 2003 | Price: $371.00 – $742.00
The market for diabetes care products covers the spectrum of clinical medicine, including diagnostics, biologics, and drugs. Several areas have strong growth potential and others, such as drugs to treat complications, represent large underserved markets for drugs primarily marketed to other populations. Segmentation of patient populations in novel ways, such as diabetic candidates for cardiovascular drugs, presents an excellent opportunity to expand markets and influence prescription practices in some markets. Scope and Methodology In addition to epidemiology of diabetes Type...
Bioinformatics Markets for Next-Generation Sequencing
Published: June 23, 2017 | Price: $1,200.00 – $2,400.00
What is the market for information technology systems used in the expanding market for next-generation sequencing (NGS)? What companies are in this space, who are they partnering with and what products are they offering? This report examines the important contribution made by information technology to the use of next-generation sequencing, and to the markets for systems and consumables. As part of its coverage, the report provides the following: Indirect Market for Bioinformatics (Including Influence on Overall NGS Market) Trends Company...
Diagnostic Test Service Commercialization in Multiplex and Esoteric Testing: A Roadmap to Diagnostics in the 21st Century
Published: August 1, 2008 | Price: $1,500.00 – $7,000.00
Test services, once the norm in the diagnostics industry, then abandoned for reagent sales, are now making a comeback. IVD companies have established cGMP and CLIA-registered labs by which they offer their proprietary tests to physicians, hospitals and reference labs. These tests are outside the oversight of the traditional FDA and CE Mark test commercialization avenue in the U.S, and Europe and so are thought to come to market by what may seem to be the back door. Kalorama has...
The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)
Published: August 9, 2013 | Price: $3,995.00 – $7,990.00
This Kalorama Information report The Market for Hospital-Acquired Infection Control (Sterilization, Cleaning, Testing, Treatment) focuses on the market for preventing, testing and treating infections in the healthcare environment. Given the cost of hospital-acquired and healthcare-associated infections (HAIs), demand has increased for solutions that can help the healthcare industry reduce infections and the costs associated with them. The U.S. Centers for Disease Control and Prevention (CDC) estimates that around 1 in 20 or 5% of hospitalized patients will contract an HAI. ...
Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets
Published: March 26, 2015 | Price: $3,995.00 – $7,990.00
Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets This report, Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets is a detailed analysis of the market opportunity for this important part of next generation sequencing applications The report includes: Market Estimate and Projection for Library Preparation and Target Enrichment Market Share by Company and Competitive Situation More Than 300 Partnerships and Deals in LP/TE New Library Preparation and Target Enrichment Products Significant Trends in the...
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition
Published: July 27, 2012 | Price: $2,995.00 – $7,990.00
In eight best-selling editions, Shara Rosen has detailed the market for in vitro diagnostic (IVD) testing, throughout the world, in one complete volume. The report, The Worldwide Market for In Vitro Diagnostic Tests, is a testament to the Kalorama methodology. Real industry knowledge combined with an exhaustive review of the medical, business, and company literature. Market numbers for business planning matched with a discovery of the trends that are impacting the industry. A realistic forecast five years into the future...
Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Published: August 1, 2010 | Price: $3,995.00 – $7,990.00
Vaccines have been one of the faster growing areas of the pharmaceutical industry, and during a troubling series of years, they have been the superstars of many companies' portfolios. They've also attracted the attention of insurance companies, retail outlets and the media. The global market for vaccines experienced strong growth through 2009 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions. Kalorama Information has been...
Cancer Liquid Biopsy Market Assessment
Published: November 8, 2017 | Price: $2,000.00 – $4,000.00
Cancer Liquid Biopsy Market Assessment (Breast Cancer, Colorectal Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer) The term liquid biopsy encompasses various diagnostic methods that use liquid, non-tissue specimens to provide information that can aid in the diagnosis, treatment and monitoring of cancer. Currently, tissue biopsies, along with imaging techniques, are the standard methods used in the diagnosis of solid cancers, but despite their widespread use, they have many limitations that open the door for other diagnostic technologies in oncology clinical...
Wellness Market Opportunities in the Aging American Population: Alternative Medicine Markets for Age-Related Health Issues
Published: September 1, 2004 | Price: $3,500.00 – $7,000.00
With an aging population in the United States, the incidence of prevalence of age-related diseases and disorders is expected to mount rapidly over the next decade. Since senior citizens already consume a disproportionate amount of healthcare dollars, the economic picture will only go from bad to worse insofar as healthcare is concerned. The solution to this problem, for this generation and the future, is prevention. The new emphasis on prevention opens up a scope of opportunity in the alternative care...
Market for Generic Biologics – Issues, Trends, and Market Potential, 2nd edition, The
Published: November 1, 2005 | Price: $2,500.00 – $5,000.00
Some of the biggest-selling biological drugs developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, are set to lose patent protection in the United States in 2005 and soon after. This opens up a market currently worth over $30 billion (and growing at over 10% per year) to generic competition, if—and it’s a big if—the regulatory hurdles for these generics can be overcome. Biogeneric is a new term combining biologic...
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Published: August 15, 2013 | Price: $3,995.00 – $7,990.00
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Circulating tumor cells (CTCs) are believed to detach from primary or secondary tumors and enter the bloodstream, traveling to distant organs and forming new tumors. These cells that leave the primary tumor are able to colonize distant organs in the body and initiate the process of metastasis; however, their biology is still not entirely elucidated. Circulating tumor cells have tremendous utility in cancer research, aiding scientists in deciphering...
Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends
Published: July 1, 2011 | Price: $150.00 – $300.00
A hospital-acquired infection (HAI)is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are excluded. This type of infection is also known as a nosocomial infection (or more generically healthcare-associated infections). The industry has responded with a variety of testing and treatment products. This report, Hospital-Acquired Infections: Diagnostic Markets and Testing Developments,...